Latest
Breakthroughs, publications, and company milestones from Seek Labs.
Data support SeekIt™, the Company’s molecular diagnostic platform’s, potential to eliminate the long-standing tradeoff between molecular performance, speed and accessibility.
Official announcements and press releases from Seek Labs.
Data support SeekIt™, the Company’s molecular diagnostic platform’s, potential to eliminate the long-standing tradeoff between molecular performance, speed and accessibility.
Seek Labs Maps 25/25 Viral Families through BioSeeker, Advancing a New Model for Sequence-Directed Antiviral Discovery The company’s comprehensive viral target atlas is designed to move development from reactive crisis response toward proactive, pre-identified genomic vulnerability mapping June 8, 2026 SALT LAKE CITY, UT (Business Wire) — Seek Labs, a private TechBio company building programmable…
Seek Labs Awarded U.S. Patent for Isothermal Molecular Amplification Chemistry Designed for Decentralized Testing Newly issued patent covers foundational amplification chemistry designed to support sensitive molecular detection without thermal cycling or centralized laboratory infrastructure May 7, 2026 SALT LAKE CITY, UT (Business Wire) — Seek Labs, a private TechBio company building programmable platforms to decode,…
The science behind the platform. Peer-reviewed and editorial publications from the Seek Labs team.
Isothermal nucleic acid amplification offers advantages over qPCR for decentralized diagnostics but remains constrained by rigid primer design, detection complexity, and equipment dependence.
Seek Labs Publishes Editorial Review on the Future of CRISPR Antivirals in an Era of AI-Designed Viral Threats December 8, 2025 Read the full open-access review in Viruses Seek Labs today announced the publication of a new editorial review in Viruses (MDPI), authored by Alison O’Mahony, Senior VP of Research, and Douglas P. Gladue, VP…
Seek Labs Publishes First Peer-Reviewed Paper Demonstrating A CRISPR-Based Therapeutic Is Effective Against African Swine Fever November 17, 2025 SALT LAKE CITY, UT (Business Wire) – Seek Labs, a biotechnology company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the publication of a peer-reviewed paper in Viruses (MDPI),…
Perspectives on programmable medicine, platform innovation, and the future of disease response.
Seek Labs recently announced BioSeeker has mapped CRISPR-addressable regions across all 25 viral families known to infect humans. That is an important infectious disease milestone.
Ebola Isn’t One Virus. We’ve Been Treating It Like One. By Jared Bauer, CEO Ebola Bundibugyo (BDBV) is the strain driving the current outbreak in the Democratic Republic of the Congo and Uganda — and it is one the world is dangerously unprepared for. “No vaccine exists. No therapy exists. The virus circulated undetected for…
For Continuously Evolving Threats like Avian Influenza, We Must Design Durable Anti-Viral Therapeutics Highly pathogenic avian influenza (HPAI) illustrates a clear and urgent application for Seek Labs’ platform based programmable therapeutic. By Dr. Douglas Gladue | March 11, 2026 Highly pathogenic avian influenza (HPAI) is a persistent and economically disruptive disease threat. It has been…
Next Generation CRISPR: How Seek Labs’ Programmable Therapeutics Are Expanding the Promise of CRISPR-Powered Innovation At Seek Labs, every day is World CRISPR Day. Our work in programmable therapeutics builds upon the same principles that make CRISPR so revolutionary: precision, adaptability, and speed. As we reflect on this transformative technology, we’re not just looking at…
We Can’t Feed the World If We Ignore Animal Disease: Why Veterinary Pathogens Are a Global Health Crisis According to the WHO, 60% of emerging infectious diseases are zoonotic. And those risks are rising as deforestation and climate shifts push animals closer to humans. By Jared bauer, Ceo of Seek Labs | July 23, 2025…
RSV Isn’t Just a Cold; It’s a Global Crisis We Keep Ignoring Why RSV is more dangerous than people think and what we’re doing to change that By Jared Bauer, CEO of Seek Labs | july 8, 2025 In January, my wife got sick. Really sick. RSV, influenza, and pneumonia, all at once. She’s a healthy,…
Data support SeekIt™, the Company’s molecular diagnostic platform’s, potential to eliminate the long-standing tradeoff between molecular performance, speed and accessibility.
BIO 2026: Where Pharma leaders Say AI Hasn’t Delivered AI hasn’t always been what it was cracked up to be in pharma. Here’s where execs say the technology hasn’t lived up to the hype. SAN DIEGO — AI adoption is still ticking up in pharma with 34% of companies leveraging the tech for specific functions,…
Panel Discusses Future of US Public Health System After Major Federal Layoffs The future of the U.S. public health system was debated by experts on June 23 during a panel at the BIO International Convention in San Diego, as recent government restructuring and staff cuts have left agencies like the Centers for Disease Control and…
Can the US public health system be rebuilt? Former FDA, CDC & NIH leaders discuss dismantling of HHS & the path to rebuilding public health.
Seek Labs recently announced BioSeeker has mapped CRISPR-addressable regions across all 25 viral families known to infect humans. That is an important infectious disease milestone.
Seek Labs Maps 25/25 Viral Families through BioSeeker, Advancing a New Model for Sequence-Directed Antiviral Discovery The company’s comprehensive viral target atlas is designed to move development from reactive crisis response toward proactive, pre-identified genomic vulnerability mapping June 8, 2026 SALT LAKE CITY, UT (Business Wire) — Seek Labs, a private TechBio company building programmable…
Seek Labs Awarded U.S. Patent for Isothermal Molecular Amplification Chemistry Designed for Decentralized Testing Newly issued patent covers foundational amplification chemistry designed to support sensitive molecular detection without thermal cycling or centralized laboratory infrastructure May 7, 2026 SALT LAKE CITY, UT (Business Wire) — Seek Labs, a private TechBio company building programmable platforms to decode,…
Dr. Alison O’Mahony Named 2026 Mentor of the Year by BioHive April 28, 2026 Dr. Alison O’Mahony, Senior Vice President of Research and Development at Seek Labs, has been named Mentor of the Year as part of BioHive’s 2026 Best of BioHive Awards. The award recognizes individuals who have made exceptional contributions to mentorship and…
Jared Bauer Named Salt Lake City Titan 100 2026 Honoree April 20, 2026 Jared Bauer, co-founder and CEO of Seek Labs, has been named a 2026 Salt Lake City Titan 100 honoree. The Titan 100 program recognizes the region’s top 100 CEOs and C-level executives, selected for their exceptional leadership, vision, and impact across industries.…
Stay connected
Stay connected to company milestones, scientific insights, and the work unfolding across BioSeeker, SAT, and Seek Diagnostics.